title: Metastatic hidradenocarcinoma: efficacy of capecitabine.
authors.forename: Thomas
authors.initials: T
authors.lastname: Jouary
authors.forename: Anastasia
authors.initials: A
authors.lastname: Kaiafa
authors.forename: Philippe
authors.initials: P
authors.lastname: Lipinski
authors.forename: Béatrice
authors.initials: B
authors.lastname: Vergier
authors.forename: Sébastien
authors.initials: S
authors.lastname: Lepreux
authors.forename: Michèle
authors.initials: M
authors.lastname: Delaunay
authors.forename: Alain
authors.initials: A
authors.lastname: Taïeb
mesh_terms: D006607:Adenoma, Sweat Gland / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001365:Axilla; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004334:Drug Administration Schedule; D004550:Elbow; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013544:Sweat Gland Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil